2020
DOI: 10.1111/boc.202000020
|View full text |Cite
|
Sign up to set email alerts
|

Pancreatic stellate cells exhibit adaptation to oxidative stress evoked by hypoxia

Abstract: Background information. Pancreatic stellate cells play a key role in the fibrosis that develops in diseases such as pancreatic cancer. In the growing tumour, a hypoxia condition develops under which cancer cells are able to proliferate. The growth of fibrotic tissue contributes to hypoxia. In this study, the effect of hypoxia (1% O 2) on pancreatic stellate cells physiology was investigated. Changes in intracellular free-Ca 2+ concentration, mitochondrial free-Ca 2+ concentration and mitochondrial membrane pot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 13 publications
(18 citation statements)
references
References 54 publications
1
17
0
Order By: Relevance
“…However, mitochondrial ROS increase slightly, and no increase in cytosolic ROS is detected. Consistent with these observations, PSCs exhibit activation of major antioxidant mechanisms to counteract the hypoxia-triggered pro-oxidative status, including augmented SOD1/2 activity, increased phosphorylation of transcription factor Nrf2, and overexpressed Nrf2-regulated antioxidant enzymes, such as the catalytic subunit of glutamate-cysteine ligase (GClc), catalase, NAD(P)H quinone oxidoreductase 1 (NQO1), and heme oxygenase-1 (HO-1) [92]. In PDAC cells, hypoxia also upregulates the expression of HO-1, which reduces intracellular ROS levels and provides a survival advantage to cancer cells [93].…”
Section: Redox Homeostasis Under Hypoxiamentioning
confidence: 65%
“…However, mitochondrial ROS increase slightly, and no increase in cytosolic ROS is detected. Consistent with these observations, PSCs exhibit activation of major antioxidant mechanisms to counteract the hypoxia-triggered pro-oxidative status, including augmented SOD1/2 activity, increased phosphorylation of transcription factor Nrf2, and overexpressed Nrf2-regulated antioxidant enzymes, such as the catalytic subunit of glutamate-cysteine ligase (GClc), catalase, NAD(P)H quinone oxidoreductase 1 (NQO1), and heme oxygenase-1 (HO-1) [92]. In PDAC cells, hypoxia also upregulates the expression of HO-1, which reduces intracellular ROS levels and provides a survival advantage to cancer cells [93].…”
Section: Redox Homeostasis Under Hypoxiamentioning
confidence: 65%
“…We have previously shown that PSCs proliferate under hypoxia [ 6 ]. Moreover, we have shown that melatonin decreases the viability of pancreatic cancer cells [ 22 ] and also of PSCs incubated under normoxia [ 19 , 20 , 21 ].…”
Section: Resultsmentioning
confidence: 99%
“…In relation to these observations, we have recently shown that PSCs proliferate under hypoxia. Similar to tumor cells, PSCs undergo certain changes that allow them to survive under a low oxygen supply [ 6 ]. Interestingly, the maneuvers developed by PSCs under low oxygen availability could contribute to fibrosis in the tumor and aid the growth of malignant cells [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the high secretion of ECM also led to the increased interstitial pressure in PDAC ( 83 ), which contributed to vascular atrophy, hypoxia, insufficient blood flow, and depletion of nutrients ( 84 ). Two recent studies indicated that under hypoxic condition, PSCs exhibited adaptation to oxidative stress and kept continuously activated, increased migration ability, and released elevated molecules like MMP-2, MMP-3 that influenced the ECM remodeling ( 85 , 86 ). The role of PSCs in remodeling TME mechanically can be further evidenced by the studies using all-trans retinoic acid (ATRA) and tamoxifen.…”
Section: The Role Of Pscs In the Aggressiveness Of Pdacmentioning
confidence: 99%